Tag Archives: Review

VIEW ALL

Sunovion Announces FDA Acceptance for Review of New Drug Application Resubmission for

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Feb 27, 2013 – SunovionPharmaceuticals Inc. (Sunovion) today announced that the U.S. Foodand Drug Administration (FDA) has accepted for review the…
Continue reading

Titan Pharmaceuticals Announces Date of FDA Advisory Committee Review of Probuphine f

SOUTH SAN FRANCISCO, February 27, 2013 – TitanPharmaceuticals, Inc. today announced that thePsychopharmacologic Drugs Advisory Committee (PDAC) of the U.S.Food and Drug Administration…
Continue reading

AVEO and Astellas Announce FDA Advisory Committee To Review Tivozanib for the Treatme

CAMBRIDGE, Mass. & NORTHBROOK, Ill.–(BUSINESS WIRE)–Feb27, 2013 – AVEO Oncology and Astellas Pharma GlobalDevelopment, Inc., a U.S. subsidiary of Tokyo-based Astellas PharmaInc., today…
Continue reading

Zogenix Provides Update on Zohydro ER Regulatory Review

SAN DIEGO, Feb. 26, 2013 (GLOBE NEWSWIRE) — Zogenix, Inc., a pharmaceutical company commercializing anddeveloping products for the treatment of central nervous systemdisorders…
Continue reading

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

PARIS, Feb. 19, 2013 /PRNewswire/ — Sanofi announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a New…
Continue reading

Raptor Pharmaceutical Corp. Provides Update on Procysbi NDA Review

NOVATO, Calif., Dec. 21, 2012 (GLOBE NEWSWIRE) — RaptorPharmaceutical Corp. ("Raptor" or the "Company"),today announced that the U.S. Food and Drug Administration ("FDA")will…
Continue reading

Genzyme’s Lemtrada (alemtuzumab) Application for MS Accepted for Review by the FDA

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan 28, 2013 – Genzyme, a Sanofi Company,announced that the U.S. Food and Drug Administration (FDA) hasaccepted for review the company’s…
Continue reading

FDA Accepts New Drug Application for Investigational Compound Dapagliflozin for the T

PRINCETON, N.J. & LONDON–(BUSINESS WIRE)–Mar 8, 2011 – Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug oeffentliche Hand…
Continue reading

FDA Accepts Lundbeck Inc. Submission of New Drug Application for Clobazam

DEERFIELD, Ill.–(BUSINESS WIRE)–Mar 4, 2011 – Lundbeck Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for review a New…
Continue reading

Smartpot – Review

Hallo Burgler, Ich baue jetzt schon seit mehreren Jahren indoor mit einem relativ gleichbleibenden Setup an. 400W NDL aufwaerts ca 0,4qm Selbstbau-Schrank (ist…
Continue reading

Hoerbuch – Mathias Broeckers & Roger Liggenstorfer – Hanf Journal

(link nur für registrierte Benutzer sichtbar, login oder registriere dich) (link nur für registrierte Benutzer sichtbar, login oder registriere dich) (link nur für…
Continue reading

Hofmanns Reisen (audioflow / nachtschatten) – Hanf Journal

(link nur für registrierte Benutzer sichtbar, login oder registriere dich)Hanf Journal… Daniel Pinchbeck's ?Den Kopf oeffnen – Eine psychedelische Reise ins Herz des…
Continue reading

VIVUS Provides Regulatory Update on Qnexa NDA

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /PRNewswire/ — VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug…
Continue reading

Adventrx Pharmaceuticals Receives PDUFA Date for Exelbine NDA

(link nur für registrierte Benutzer sichtbar, login oder registriere dich) (link nur für registrierte Benutzer sichtbar, login oder registriere dich) (link nur für…
Continue reading

Pot Bylaw Suspension ?precedent Setting?

Crowd Piles into Mission Chambers The B.C.* Civil Liberties Association is hoping the recent suspension of a controversial Mission bylaw will set a…
Continue reading
 

Facebook

    Subscribe Contact Me Popular Social
 
Thank you for subscription!
 
Thank you! Your message has been submitted to us.